| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylethanolamine transfer activity | 3.68e-05 | 4 | 50 | 2 | GO:1904121 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transfer activity | 9.16e-05 | 6 | 50 | 2 | GO:0120019 | |
| GeneOntologyMolecularFunction | lipid binding | 6.88e-04 | 988 | 50 | 9 | GO:0008289 | |
| GeneOntologyMolecularFunction | metallochaperone activity | 9.16e-04 | 18 | 50 | 2 | GO:0016530 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 1.13e-03 | 20 | 50 | 2 | GO:0008525 | |
| GeneOntologyMolecularFunction | carbohydrate kinase activity | 1.25e-03 | 21 | 50 | 2 | GO:0019200 | |
| GeneOntologyMolecularFunction | cholesterol transfer activity | 1.64e-03 | 24 | 50 | 2 | GO:0120020 | |
| GeneOntologyMolecularFunction | sterol transfer activity | 1.78e-03 | 25 | 50 | 2 | GO:0120015 | |
| GeneOntologyMolecularFunction | phospholipid transfer activity | 1.92e-03 | 26 | 50 | 2 | GO:0120014 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 1.92e-03 | 26 | 50 | 2 | GO:0031420 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 2.65e-03 | 231 | 50 | 4 | GO:0005085 | |
| GeneOntologyBiologicalProcess | regulation of ARF protein signal transduction | 2.29e-05 | 23 | 50 | 3 | GO:0032012 | |
| GeneOntologyBiologicalProcess | ARF protein signal transduction | 2.62e-05 | 24 | 50 | 3 | GO:0032011 | |
| GeneOntologyBiologicalProcess | response to iron ion | 5.74e-05 | 31 | 50 | 3 | GO:0010039 | |
| GeneOntologyBiologicalProcess | establishment of cell polarity | 6.82e-05 | 177 | 50 | 5 | GO:0030010 | |
| GeneOntologyCellularComponent | secretory granule | AMPD3 ATP8B4 IGF2R ATP7A ANXA3 TRPM2 CYP51A1 FNDC3A TF TXNDC8 SPINK5 | 2.64e-05 | 1014 | 51 | 11 | GO:0030141 |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 1.65e-04 | 212 | 51 | 5 | GO:0030666 | |
| GeneOntologyCellularComponent | secretory vesicle | AMPD3 ATP8B4 IGF2R ATP7A ANXA3 TRPM2 CYP51A1 FNDC3A TF TXNDC8 SPINK5 | 1.69e-04 | 1246 | 51 | 11 | GO:0099503 |
| GeneOntologyCellularComponent | endocytic vesicle | 3.31e-04 | 384 | 51 | 6 | GO:0030139 | |
| Domain | - | 8.53e-06 | 15 | 51 | 3 | 1.10.1000.11 | |
| Domain | Sec7 | 8.53e-06 | 15 | 51 | 3 | PF01369 | |
| Domain | Sec7_alpha_orthog | 8.53e-06 | 15 | 51 | 3 | IPR023394 | |
| Domain | Sec7 | 1.05e-05 | 16 | 51 | 3 | SM00222 | |
| Domain | SEC7 | 1.05e-05 | 16 | 51 | 3 | PS50190 | |
| Domain | Sec7_dom | 1.05e-05 | 16 | 51 | 3 | IPR000904 | |
| Domain | SCP2_sterol-bd_dom | 7.27e-05 | 5 | 51 | 2 | IPR003033 | |
| Domain | - | 7.27e-05 | 5 | 51 | 2 | 3.30.1050.10 | |
| Domain | SCP2 | 7.27e-05 | 5 | 51 | 2 | PF02036 | |
| Domain | - | 5.59e-04 | 13 | 51 | 2 | 2.10.10.10 | |
| Domain | Thioredoxin | 5.59e-04 | 13 | 51 | 2 | IPR005746 | |
| Domain | FN_type2_col-bd | 6.51e-04 | 14 | 51 | 2 | IPR000562 | |
| Domain | FN2_2 | 6.51e-04 | 14 | 51 | 2 | PS51092 | |
| Domain | fn2 | 6.51e-04 | 14 | 51 | 2 | PF00040 | |
| Domain | FN2_1 | 6.51e-04 | 14 | 51 | 2 | PS00023 | |
| Domain | FN2 | 6.51e-04 | 14 | 51 | 2 | SM00059 | |
| Domain | - | 1.49e-03 | 21 | 51 | 2 | 3.30.230.10 | |
| Domain | Ribosomal_S5_D2-typ_fold_subgr | 1.63e-03 | 22 | 51 | 2 | IPR014721 | |
| Domain | THIOREDOXIN_1 | 2.11e-03 | 25 | 51 | 2 | PS00194 | |
| Domain | Thioredoxin | 3.23e-03 | 31 | 51 | 2 | PF00085 | |
| Domain | Kringle-like | 3.44e-03 | 32 | 51 | 2 | IPR013806 | |
| Domain | - | 3.44e-03 | 32 | 51 | 2 | 3.40.1110.10 | |
| Domain | - | 3.44e-03 | 32 | 51 | 2 | 2.70.150.10 | |
| Domain | Ribosomal_S5_D2-typ_fold | 3.88e-03 | 34 | 51 | 2 | IPR020568 | |
| Domain | ATPase_P-typ_cyto_domN | 4.11e-03 | 35 | 51 | 2 | IPR023299 | |
| Domain | P_typ_ATPase | 4.34e-03 | 36 | 51 | 2 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 4.34e-03 | 36 | 51 | 2 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 4.34e-03 | 36 | 51 | 2 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 4.58e-03 | 37 | 51 | 2 | IPR008250 | |
| Domain | E1-E2_ATPase | 4.58e-03 | 37 | 51 | 2 | PF00122 | |
| Pathway | BIOCARTA_ARAP_PATHWAY | 4.93e-06 | 12 | 41 | 3 | MM1342 | |
| Pathway | BIOCARTA_ARAP_PATHWAY | 1.51e-05 | 17 | 41 | 3 | M2482 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 5.02e-05 | 25 | 41 | 3 | M47716 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGD_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 7.92e-05 | 29 | 41 | 3 | M47717 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 8.78e-05 | 30 | 41 | 3 | M47738 | |
| Pathway | REACTOME_INTRA_GOLGI_TRAFFIC | 1.66e-04 | 37 | 41 | 3 | MM15354 | |
| Pathway | REACTOME_INTRA_GOLGI_TRAFFIC | 2.78e-04 | 44 | 41 | 3 | M27652 | |
| Pathway | PID_PI3KCI_PATHWAY | 3.61e-04 | 48 | 41 | 3 | M141 | |
| Pubmed | 2.97e-09 | 3 | 51 | 3 | 18042453 | ||
| Pubmed | Complex regulation of multiple cytohesin-like genes in murine tissues and cells. | 2.97e-09 | 3 | 51 | 3 | 9744817 | |
| Pubmed | 1.19e-08 | 4 | 51 | 3 | 10652308 | ||
| Pubmed | 1.19e-08 | 4 | 51 | 3 | 12606567 | ||
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 12920129 | ||
| Pubmed | INAVA-ARNO complexes bridge mucosal barrier function with inflammatory signaling. | 5.92e-08 | 6 | 51 | 3 | 30355448 | |
| Pubmed | 1.65e-07 | 8 | 51 | 3 | 17398095 | ||
| Pubmed | FRMD4A regulates epithelial polarity by connecting Arf6 activation with the PAR complex. | 1.65e-07 | 8 | 51 | 3 | 20080746 | |
| Pubmed | 2.48e-07 | 9 | 51 | 3 | 17846866 | ||
| Pubmed | EXOSC10 IGF2R ATP7A RRP12 CYP51A1 BAG1 BAZ1B BCCIP FNDC3A RAB11FIP1 DNAJB14 TXN | 1.20e-06 | 1487 | 51 | 12 | 33957083 | |
| Pubmed | Cytohesin-1, a cytosolic guanine nucleotide-exchange protein for ADP-ribosylation factor. | 2.11e-06 | 2 | 51 | 2 | 9050849 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 31601460 | ||
| Pubmed | A crucial role for Arf6 in the response of commissural axons to Slit. | 2.83e-06 | 19 | 51 | 3 | 30674481 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 31022698 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 8706128 | ||
| Pubmed | Phosphoinositide specificity determines which cytohesins regulate β1 integrin recycling. | 6.32e-06 | 3 | 51 | 2 | 22454518 | |
| Pubmed | C1orf106 is a colitis risk gene that regulates stability of epithelial adherens junctions. | 8.48e-06 | 27 | 51 | 3 | 29420262 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 12052827 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 23806407 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 10748148 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 21041639 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 18805052 | ||
| Pubmed | Four human chromosome 3q and four human chromosome 21 loci map onto sheep chromosome 1q. | 4.41e-05 | 7 | 51 | 2 | 7749229 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 5.44e-05 | 457 | 51 | 6 | 32344865 | |
| Pubmed | 9.42e-05 | 10 | 51 | 2 | 10828067 | ||
| Pubmed | 1.38e-04 | 12 | 51 | 2 | 33251042 | ||
| Pubmed | 2.58e-04 | 210 | 51 | 4 | 16565220 | ||
| Pubmed | 2.83e-04 | 17 | 51 | 2 | 17634284 | ||
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 3.19e-04 | 90 | 51 | 3 | 35654790 | |
| Pubmed | 3.73e-04 | 652 | 51 | 6 | 31180492 | ||
| Pubmed | 4.35e-04 | 21 | 51 | 2 | 32591430 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 5.51e-04 | 1294 | 51 | 8 | 30804502 | |
| Pubmed | 6.53e-04 | 115 | 51 | 3 | 20485444 | ||
| Pubmed | 6.64e-04 | 1014 | 51 | 7 | 32416067 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | 6.85e-04 | 732 | 51 | 6 | 34732716 | |
| Pubmed | Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer. | 6.87e-04 | 117 | 51 | 3 | 19124506 | |
| Pubmed | 7.23e-04 | 27 | 51 | 2 | 17244351 | ||
| Pubmed | 7.57e-04 | 121 | 51 | 3 | 22412018 | ||
| Pubmed | A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers. | 7.57e-04 | 121 | 51 | 3 | 19789190 | |
| Pubmed | 7.70e-04 | 493 | 51 | 5 | 15368895 | ||
| Pubmed | 7.99e-04 | 754 | 51 | 6 | 35906200 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 9.15e-04 | 774 | 51 | 6 | 15302935 | |
| Pubmed | BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs. | 9.54e-04 | 31 | 51 | 2 | 23086144 | |
| Pubmed | 9.54e-04 | 31 | 51 | 2 | 19690177 | ||
| Pubmed | TXLNA enhances TBK1 phosphorylation by suppressing PPM1B recruitment. | 1.11e-03 | 138 | 51 | 3 | 37506885 | |
| Pubmed | Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma. | 1.22e-03 | 35 | 51 | 2 | 20855536 | |
| Pubmed | 1.43e-03 | 332 | 51 | 4 | 25693804 | ||
| Pubmed | 1.45e-03 | 333 | 51 | 4 | 36779763 | ||
| Pubmed | 1.45e-03 | 847 | 51 | 6 | 35850772 | ||
| Interaction | IPCEF1 interactions | 2.48e-06 | 11 | 51 | 3 | int:IPCEF1 | |
| Interaction | CYTIP interactions | 1.01e-05 | 17 | 51 | 3 | int:CYTIP | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q23 | 7.86e-04 | 37 | 51 | 2 | chr4q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q21 | 1.02e-03 | 177 | 51 | 3 | chr15q21 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.72e-03 | 206 | 30 | 3 | 682 | |
| Coexpression | TBK1.DF_DN | 1.91e-05 | 286 | 51 | 6 | M2864 | |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN | 2.56e-05 | 179 | 51 | 5 | M16932 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 3.60e-05 | 856 | 51 | 9 | M4500 | |
| Coexpression | GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_DN | 4.14e-05 | 198 | 51 | 5 | M6068 | |
| Coexpression | GSE14308_TH1_VS_INDUCED_TREG_DN | 4.35e-05 | 200 | 51 | 5 | M3379 | |
| Coexpression | GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN | 4.35e-05 | 200 | 51 | 5 | M7432 | |
| Coexpression | RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP | 5.10e-05 | 341 | 51 | 6 | M12636 | |
| Coexpression | DESCARTES_ORGANOGENESIS_HEPATOCYTES | 7.55e-05 | 535 | 51 | 7 | MM3635 | |
| Coexpression | RUTELLA_RESPONSE_TO_HGF_DN | 1.03e-04 | 240 | 51 | 5 | M6413 | |
| ToppCell | severe-unassigned|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.64e-07 | 128 | 51 | 5 | bef9cf0078fa8498d63f0723f1fa4a3c92405e10 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.32e-06 | 166 | 51 | 5 | 575c325db88d6909cdf0d5e664bd9098b89d4401 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 1.66e-06 | 174 | 51 | 5 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.76e-06 | 176 | 51 | 5 | b6497324e3e52f514ce556a3fa0c3011c45dcc7b | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-HSC-MPP|bone_marrow / Manually curated celltypes from each tissue | 2.83e-06 | 194 | 51 | 5 | 3a7e7acbddc63da44d9a04a5b52adf6934fc83dd | |
| ToppCell | severe-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.05e-06 | 197 | 51 | 5 | 70704b149b2820b8601d2495b7cd9cbe91eda262 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.21e-06 | 199 | 51 | 5 | b7af2b4fe6866cc8c78cf0f78390aab1b1b389ba | |
| ToppCell | facs-BAT-Fat-18m-Myeloid-granulocyte|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-05 | 169 | 51 | 4 | d3e6c75e5eda133fb6535cfe6c6a1026641f26ac | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.38e-05 | 171 | 51 | 4 | af1c93eb75f45c042ea475d93db56e4da207e31f | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.58e-05 | 173 | 51 | 4 | b9dee61973559e8c2fef3f2dafd43475b386befb | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Control / Condition, Lineage and Cell class | 4.69e-05 | 174 | 51 | 4 | 4c64ff5666812fb4efa440ba4faeca51d916d68e | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 4.69e-05 | 174 | 51 | 4 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 5.01e-05 | 177 | 51 | 4 | 470f54fe2b21c7350ea471e02039461a3808f700 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.82e-05 | 184 | 51 | 4 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.82e-05 | 184 | 51 | 4 | 29c95b814a0b1ad8734ed68b77df29c08594e5ec | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.82e-05 | 184 | 51 | 4 | d48807f9da48bdd015a54c606d2e2a311f181396 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.82e-05 | 184 | 51 | 4 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.20e-05 | 187 | 51 | 4 | edb0ab0154542b1c0b3a2c216c4a60f0f06290b3 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Basophil|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.33e-05 | 188 | 51 | 4 | 3638d85452de15a060146628fbbad9d2a36feb13 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.46e-05 | 189 | 51 | 4 | 7899af78b273d9c7f029d52f7e0cf6df4da41f5e | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.59e-05 | 190 | 51 | 4 | a34293601aefe5fb5c400c14091294b9ddaa195b | |
| ToppCell | pdx-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.59e-05 | 190 | 51 | 4 | b05db0de9b6ae01dd30074453f7de44f7397631e | |
| ToppCell | hematopoetic_progenitors|World / Lineage and Cell class | 6.73e-05 | 191 | 51 | 4 | bc77789297974587d51f9e4fae22cea5f499354d | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_2|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.87e-05 | 192 | 51 | 4 | 0445fdc670fa7b847dcd0a061d7736ddcf3519ba | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.01e-05 | 193 | 51 | 4 | 5dfa69a680a0859900141c40a446d217aaa747d3 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.01e-05 | 193 | 51 | 4 | ebea35704ac5d21e947ae094313cf2a5205e7014 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-airway_progenitor_early|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.01e-05 | 193 | 51 | 4 | de569c6e507856fd3ac2311f246cb597074ed30c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.15e-05 | 194 | 51 | 4 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.15e-05 | 194 | 51 | 4 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 7.44e-05 | 196 | 51 | 4 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | AT2_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 7.58e-05 | 197 | 51 | 4 | fd7bdfa6bf5966ebc11fdd13915769429540ddbf | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.58e-05 | 197 | 51 | 4 | adb4e27d73ae2e6a39d212c0ead3ac0ad62d9131 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil-promyelocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.58e-05 | 197 | 51 | 4 | cfc9decbfa9ebadafda8b620ec529d3fcdd15dcd | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.73e-05 | 198 | 51 | 4 | 7f7024b26337ae2bc7f57c3274a7dfdaaa64ab7c | |
| ToppCell | 3'-Adult|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.73e-05 | 198 | 51 | 4 | 302adb42089ff22fffc4f01af572ca2e151f7ce7 | |
| ToppCell | 5'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.73e-05 | 198 | 51 | 4 | db26c20321f9ab102d6484f22ddb2bde684067b1 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.73e-05 | 198 | 51 | 4 | 59214e34b077dffa989c48635fdef143f57f1320 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.89e-05 | 199 | 51 | 4 | 9d24223b571fba202455c5bd49bd79530abf09c0 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.89e-05 | 199 | 51 | 4 | 722b9ebf7e47c361a7f192689a8d46947ec62b45 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.89e-05 | 199 | 51 | 4 | f544229f471b4717166dd4b588399afe45cc31b5 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.89e-05 | 199 | 51 | 4 | 06cf08b4a60670f583895a79488524b7b386b2f0 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.89e-05 | 199 | 51 | 4 | 5f77d3892db7b0d657870ccd596e08a411928bfc | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.89e-05 | 199 | 51 | 4 | a1635a52318be0423f8e4fc03d971c28cd22b57e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.04e-05 | 200 | 51 | 4 | 5bff27963fbfc8d0ce2b6e073fba5121fbe8d5a1 | |
| ToppCell | control-Epithelial|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.04e-05 | 200 | 51 | 4 | f95bbb94e51ac28b1995026c599ec3a34e012916 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-immature_Neutrophil|COVID-19_Severe / Disease, condition lineage and cell class | 8.04e-05 | 200 | 51 | 4 | cbe667eda1af222467df8bfa157aa22df488f133 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Transitional_AT2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 8.04e-05 | 200 | 51 | 4 | dfa897ef5ce4744c77b6e5ee5a0d6d83229d1691 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.04e-05 | 200 | 51 | 4 | be46efc899d06c55ee297bee3126f69bcdb2048b | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.04e-05 | 200 | 51 | 4 | 808571d74bb5c4d765ff13fc9393f88020d4e90d | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Transitional_AT2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.04e-05 | 200 | 51 | 4 | 992bd6b1feac2afded6eb927ac95ddf5cfef961c | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Transitional_AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.04e-05 | 200 | 51 | 4 | 8d1c78dd829cbc290820d5118f24ff7f828a8622 | |
| ToppCell | mild-immature_Neutrophil|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.18e-04 | 83 | 51 | 3 | f7225bc24ad6df3a41375cc4614af824e0db3559 | |
| ToppCell | mild-immature_Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.65e-04 | 109 | 51 | 3 | 2f03d6ee8b13424cc6a5bc60ac3461b44dff9d79 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.87e-04 | 112 | 51 | 3 | 9c3fb470708e76a8f8a3cb9aa17ab130c60fee11 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-IRC-IFNG_responsive_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.06e-04 | 136 | 51 | 3 | 7f1ca43e0d164b511120316d4218d80ba21a9b5c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-04 | 144 | 51 | 3 | f6061dd965a2b2fe6ad864f8aecc06d2e74881ce | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.97e-04 | 144 | 51 | 3 | c0c5f254a960ba5e5f1354599d54e77360e6c2ac | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.97e-04 | 144 | 51 | 3 | 1efa434e577d1f87e02df01667782f414d63bd60 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-MPP_myeloid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.73e-04 | 150 | 51 | 3 | 040468880f69b050c7e992749a165280eb6e61ef | |
| ToppCell | 343B-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.26e-04 | 154 | 51 | 3 | 71d33b5dbfab5820e3daddb01806a69116ba8008 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 7.96e-04 | 159 | 51 | 3 | af137688e06a97ff97bb7def54f0dd164d155b11 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.11e-04 | 160 | 51 | 3 | 5d8d97c3da5837ba5fe743d2f8438f5cb7cea64b | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.26e-04 | 161 | 51 | 3 | f5da03c426f3124ea302bd343b6bca81cafee858 | |
| ToppCell | primary_visual_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Ctla2a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.26e-04 | 161 | 51 | 3 | a60ef3f390f56bb05b687b17986fe6382f69f260 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.41e-04 | 162 | 51 | 3 | 4e3bf16799c6552366d4c7e42b1328a05dcad7e7 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.41e-04 | 162 | 51 | 3 | d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918 | |
| ToppCell | primary_visual_cortex-Non-neuronal-endothelial_cell-Endo|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.41e-04 | 162 | 51 | 3 | 0bdb1e5ba33e162bec1acb28256c1405a7658ee5 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.41e-04 | 162 | 51 | 3 | 06f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3 | |
| ToppCell | primary_visual_cortex-Non-neuronal-endothelial_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.41e-04 | 162 | 51 | 3 | 5799a602ef8d83925907e8e34532428be7330228 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.71e-04 | 164 | 51 | 3 | 54f8f11d2fa899005530c08e7a1ee728c7b0799c | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.71e-04 | 164 | 51 | 3 | 6a41a159134e605b80d5e731f9ed5bc803bb531b | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells-Airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.71e-04 | 164 | 51 | 3 | b1243b10591e1e15a94952e39ffbf382eae6aae8 | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell-Endo|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.71e-04 | 164 | 51 | 3 | ec68954fc09b6850273b5e59caa6b09d02151097 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.71e-04 | 164 | 51 | 3 | 56e6934e6c7503a300d7be06762d45a1d6f1ae0f | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.71e-04 | 164 | 51 | 3 | c5b2001280a43da855017361a3f6071a0e492848 | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial-AT1|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 8.86e-04 | 165 | 51 | 3 | b9b6b7b8cd65ba6948a5dd8b715cc7092e0be637 | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Ctla2a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.02e-04 | 166 | 51 | 3 | 27af6c906cff1d40d134f0386db7708869691121 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-04 | 168 | 51 | 3 | 3611605114f6b668b44728d6563cd02389e106af | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.50e-04 | 169 | 51 | 3 | 3f738fc56bbc70dc77c9ba41025631f8264cd2b3 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.50e-04 | 169 | 51 | 3 | f38b52972a6c492ce2fd520a26bb3fc8db23bf85 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.50e-04 | 169 | 51 | 3 | 1558606be0a8bcd4fd0ce609701a1411e4ca2f9f | |
| ToppCell | facs-Marrow-Granulocytes-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.50e-04 | 169 | 51 | 3 | ee1969755180df58d32904e2bb4192da9373d03e | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.50e-04 | 169 | 51 | 3 | 1b2354de1ce4080118d9f01e7c5fd6079e705125 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-Microfold_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.50e-04 | 169 | 51 | 3 | a54a8494c1feff29d77ab4737fcfabc84ace5c94 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.50e-04 | 169 | 51 | 3 | 5320da1d61806b53e0bd96bbdfdb8fd69246681b | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 9.66e-04 | 170 | 51 | 3 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-04 | 170 | 51 | 3 | d7c9a604311974ff87ece43a0f8725a234d262f7 | |
| ToppCell | facs-BAT-Fat-3m-Myeloid-granulocyte|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-04 | 170 | 51 | 3 | 8fd0a55266066a51266ab616c38c883e2680bcf4 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-hematopoietic_progenitor-erythroid_progenitor_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.66e-04 | 170 | 51 | 3 | 74bb46826141bd1e80b4ce16e6bbfc770bd427d3 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-hematopoietic_progenitor|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.66e-04 | 170 | 51 | 3 | 6592ebe204b43b81c6b6da99e05da72c0983b3fa | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.83e-04 | 171 | 51 | 3 | ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.83e-04 | 171 | 51 | 3 | fea6ef6bbfebea2dd0f0360c7db7a5e858f15958 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.83e-04 | 171 | 51 | 3 | f15594fd4d709920733de9376a391dedc62b65de | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-pDCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 9.83e-04 | 171 | 51 | 3 | 1f8e66073088fc1969782e443bf00f8c1877ea91 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.83e-04 | 171 | 51 | 3 | 97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T|bone_marrow / Manually curated celltypes from each tissue | 9.99e-04 | 172 | 51 | 3 | a66402d15853f0c9e3d06394ff9ac08d1da128ff | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.99e-04 | 172 | 51 | 3 | ef33b5e0515c6d29fb6d9a673011c1b68ef264f3 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-03 | 173 | 51 | 3 | 45808cf69122c16b9d2b5ffa06d15392c55954b7 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-03 | 173 | 51 | 3 | 0b79e2a4fd19d524c24b69a6b524ffc6affdabe5 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-03 | 173 | 51 | 3 | ef8d720b99470fe1953661f6e66bc0366266bdb6 | |
| Drug | SecinH3 | 8.81e-07 | 9 | 51 | 3 | CID001029232 | |
| Drug | Metronidazole [443-48-1]; Down 200; 23.4uM; HL60; HG-U133A | 5.06e-06 | 197 | 51 | 6 | 2003_DN | |
| Drug | Nialamide [51-12-7]; Up 200; 13.4uM; PC3; HT_HG-U133A | 5.21e-06 | 198 | 51 | 6 | 4525_UP | |
| Disease | Aortic Rupture | 2.69e-05 | 5 | 49 | 2 | C0003496 | |
| Disease | Aortic Aneurysm, Ruptured | 2.69e-05 | 5 | 49 | 2 | C0741160 | |
| Disease | Neointima Formation | 4.04e-05 | 6 | 49 | 2 | C2936381 | |
| Disease | Neointima | 4.04e-05 | 6 | 49 | 2 | C2936380 | |
| Disease | Cancer of Nasopharynx | 9.65e-05 | 9 | 49 | 2 | C0238301 | |
| Disease | Nasopharyngeal Neoplasms | 9.65e-05 | 9 | 49 | 2 | C0027439 | |
| Disease | salicylate measurement | 1.47e-04 | 11 | 49 | 2 | EFO_0021161 | |
| Disease | mean corpuscular hemoglobin concentration | 4.34e-04 | 1105 | 49 | 8 | EFO_0004528 | |
| Disease | uric acid measurement | 5.01e-04 | 610 | 49 | 6 | EFO_0004761 | |
| Disease | citrulline measurement | 5.04e-04 | 20 | 49 | 2 | EFO_0009777 | |
| Disease | gallstones | 7.77e-04 | 108 | 49 | 3 | EFO_0004210 | |
| Disease | Pancytopenia | 8.56e-04 | 26 | 49 | 2 | C0030312 | |
| Disease | metabolic disease, COVID-19 | 8.56e-04 | 26 | 49 | 2 | EFO_0000589, MONDO_0100096 | |
| Disease | lipoprotein A measurement | 8.64e-04 | 112 | 49 | 3 | EFO_0006925 | |
| Disease | hypertension, COVID-19 | 9.23e-04 | 27 | 49 | 2 | EFO_0000537, MONDO_0100096 | |
| Disease | glaucoma (biomarker_via_orthology) | 9.93e-04 | 28 | 49 | 2 | DOID:1686 (biomarker_via_orthology) | |
| Disease | Alzheimer disease | 1.24e-03 | 485 | 49 | 5 | MONDO_0004975 | |
| Disease | coffee consumption | 1.30e-03 | 32 | 49 | 2 | EFO_0004330 | |
| Disease | fatty liver disease (biomarker_via_orthology) | 1.38e-03 | 33 | 49 | 2 | DOID:9452 (biomarker_via_orthology) | |
| Disease | ovarian neoplasm | 1.45e-03 | 134 | 49 | 3 | C0919267 | |
| Disease | Anemia | 1.46e-03 | 34 | 49 | 2 | C0002871 | |
| Disease | pelvic organ prolapse | 1.51e-03 | 136 | 49 | 3 | EFO_0004710 | |
| Disease | Malignant neoplasm of ovary | 1.54e-03 | 137 | 49 | 3 | C1140680 | |
| Disease | serine measurement | 1.55e-03 | 35 | 49 | 2 | EFO_0009774 | |
| Disease | vitamin D-binding protein measurement | 1.64e-03 | 36 | 49 | 2 | EFO_0005675 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KKFLQGFMAPKQKRR | 1106 | Q9UIG0 | |
| MKGDQAKGKKPLFVQ | 281 | Q7Z2Z2 | |
| PAVFDAKQLKKSMKG | 91 | P12429 | |
| SFQKLIFKGKSLKEM | 186 | Q99933 | |
| PDTKLMQNSGKTKFK | 251 | Q8TF62 | |
| LTVKGKEPFIKMKQF | 601 | O14529 | |
| FKLPKKHMQLGDFMK | 641 | A2RUS2 | |
| RSKKLLPNFGKMLEN | 481 | Q01432 | |
| KKQIEAMGFPAFVKK | 226 | Q04656 | |
| KDTLKKMQKFFGLPQ | 71 | P08253 | |
| KFKENGKMFKDKVSP | 611 | Q03112 | |
| MNIGIFLKQFKKSPR | 176 | Q9C0D6 | |
| LANGAFMPKKSIKKL | 586 | P52948 | |
| KKRKCMQPKDFNFKT | 106 | Q8NEM0 | |
| FMKNGKLFCPQDKKF | 36 | Q9NQ38 | |
| SQLQMQKIFKKLPGF | 266 | Q17R60 | |
| KKPSNKKKAALMFAN | 236 | Q9P287 | |
| GKKQVPCFASMLTKK | 271 | P55212 | |
| IFKGKSPSKIMGKEN | 101 | P55157 | |
| KLKEMFNSKFGSIPK | 21 | Q01415 | |
| KKFNMDPKKGIQFLI | 71 | Q15438 | |
| KTEIPMGKNYNKLKN | 81 | O43766 | |
| VSKKPGHTKKMNFFK | 141 | Q8N3Z3 | |
| DLMQKIKQQKGKLFP | 86 | P51956 | |
| QKQKVPLGTFRKDMK | 541 | Q9Y6X9 | |
| IKNFKPSPSKNKGMF | 1231 | Q9BX63 | |
| KKIKQSVGNKSMSFP | 856 | Q01780 | |
| FLKAMLSTGFKIPQK | 1346 | P31327 | |
| DPFLKNMKKLLKLDF | 201 | Q9HB55 | |
| MKGEIVKKYTQFNPK | 426 | Q9Y223 | |
| KNLKERFFIKPQSMG | 2111 | Q9H799 | |
| NKDFKNEYKGMLLQK | 301 | Q8TBM8 | |
| KQFKITKLSPAMGCK | 426 | Q9Y2H6 | |
| PVFLEQKKMLKSGLN | 156 | Q16850 | |
| KFNMDPKKGIQFLVE | 71 | Q99418 | |
| KFNMDPKKGIQFLIE | 76 | O43739 | |
| RKLGNFTKPEMKVNF | 801 | Q9Y2H2 | |
| KNLGKFISSPMKEKG | 546 | P11717 | |
| SMKDKSRNPFGKLKD | 161 | Q6WKZ4 | |
| NQKKKMIFQPQLFKD | 96 | A1A4F0 | |
| GKMNPQKAFLAGKFK | 121 | Q9UJQ7 | |
| NKKTFIVMNKGKAIF | 86 | Q9NY46 | |
| KMNPQSAFFQGKLKI | 511 | P22307 | |
| KMKLQGQFKGLVKAA | 1266 | Q5JTH9 | |
| VKCMPTFQFFKKGQK | 71 | P10599 | |
| KKDSGFQMNQLRGKK | 121 | P02787 | |
| GAKNFNMKPRLKSIF | 176 | O94759 | |
| MKNFLFPPQKLEKKI | 1076 | Q9C0B7 | |
| MKQKQKFVDKPGPFV | 401 | Q8IV63 | |
| ADFGKIMKNVFPNMK | 51 | Q2KHR2 | |
| IKTIPTFQMFKKSQK | 71 | Q6A555 | |
| NIQNMILKLKKGKFP | 351 | Q9UHQ1 |